Aranesp 300 MCG/0.6 ML syringe 0.6ML
Ended Awarded
- Contract number
- SPE2DR26FXP9M
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $4,187
Award facts
- Contract value 100% obligated
- $4,187.10 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $4,187.10 to AmerisourceBergen Drug Corp for Aranespâ„¢ 300 micrograms/0.6 milliliter syringes on November 4, 2025, with completion targeted for November 5, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and is being performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $1 billion comprehensive pharmaceutical support vehicle running through December 2026.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, leverages its prime IDC with the DLA to supply critical medical commodities across therapeutic domains to support military healthcare programs globally. The company's federal procurement portfolio demonstrates consistent capability to fulfill competitive awards for brand-name and generic medications, specialty pharmaceuticals, vaccines, and medical supplies for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. This particular delivery order for Aranespâ„¢—an erythropoiesis-stimulating agent used in treating anemia—exemplifies the ongoing pharmaceutical supply needs within the federal healthcare system supported through DLA's medical supply chain operations.
Quick answers
Who was awarded contract SPE2DR26FXP9M?
SPE2DR26FXP9M was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 4, 2025.
How much is contract SPE2DR26FXP9M worth?
The government has obligated $4,187 on SPE2DR26FXP9M.
Is contract SPE2DR26FXP9M an order under another contract?
Yes. SPE2DR26FXP9M is a delivery order under SPE2DR25D6029, an indefinite delivery contract.
Was contract SPE2DR26FXP9M competed?
The extent of competition for SPE2DR26FXP9M was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award